Stammdaten
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning. The company was incorporated in 2003 and is based in Sunnyvale, California.
Unternehmen & Branche
| Name | EBR Systems, Inc. |
|---|---|
| Ticker | EBRCZ |
| CIK | 0001347123 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Specialties |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | CDI |
| Marktkapitalisierung | 316,1 Mio. USD |
| Beta | 0,56 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 1,617,000 | -48,758,000 | -0.12 | 97,226,000 | 25,588,000 |
| 2025-09-30 | 10-Q | 512,093 | -12,188,854 | -0.03 | 104,991,554 | 38,650,515 |
| 2025-06-30 | 10-Q | 169,704 | -11,967,441 | -0.03 | 114,930,318 | 49,696,129 |
| 2025-03-31 | 10-Q | -10,554,271 | -0.03 | 75,500,875 | 14,558,760 | |
| 2024-12-31 | 10-K | -40,799,000 | -0.13 | 73,560,000 | 24,356,000 | |
| 2024-09-30 | 10-Q | -10,055,917 | -0.03 | 78,823,613 | 31,236,442 | |
| 2024-06-30 | 10-Q | -11,494,688 | -0.04 | 11,209,284 | ||
| 2024-03-31 | 10-Q | -9,150,003 | -0.03 | 22,295,997 | ||
| 2023-12-31 | 10-K | -35,036,888 | -0.12 | 78,898,477 | 31,057,000 | |
| 2023-09-30 | 10-Q | -9,132,465 | -0.03 | 40,814,055 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.